Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-13-003036
Filing Date
2013-05-20
Accepted
2013-05-20 13:42:44
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 c73741_10q.htm 10-Q 219561
2 c73741_ex31-1.htm EX-31.1 9467
3 c73741_ex31-2.htm EX-31.2 9489
4 c73741_ex32-1.htm EX-32.1 3748
5 c73741_ex32-2.htm EX-32.2 3651
  Complete submission text file 0000930413-13-003036.txt   2133736

Data Files

Seq Description Document Type Size
6 ibio-20130331.xml EX-101.INS 192395
7 ibio-20130331.xsd EX-101.SCH 30026
8 ibio-20130331_cal.xml EX-101.CAL 18250
9 ibio-20130331_def.xml EX-101.DEF 164562
10 ibio-20130331_lab.xml EX-101.LAB 202819
11 ibio-20130331_pre.xml EX-101.PRE 165974
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 13857679
SIC: 2834 Pharmaceutical Preparations